Filings

7 documents · 102 matches

1. XLO Xilio Therapeutics, Inc. 10-Q 2026-05-12

   Item 1A. Risk Factors

   tariffs, invalidating both the “reciprocal” tariffs and certain country-specific tariffs. The President subsequently invoked Section 122 of the Trade
   13 matches in this document Show context Copy citation

2. XLO Xilio Therapeutics, Inc. 10-Q 2025-11-13

   Item 1A. Risk Factors

   tariff of 10% on all U.S. trading partners effective April 5, 2025, and higher individualized reciprocal tariffs on 57 countries
   17 matches in this document Show context Copy citation

3. XLO Xilio Therapeutics, Inc. 10-Q 2025-08-14

   Item 1A. Risk Factors

   tariffs were scheduled to take effect, the U.S. delayed the effective date of such tariffs for all countries except China
   16 matches in this document Show context Copy citation

4. XLO Xilio Therapeutics, Inc. 10-Q 2025-05-08

   Item 1A. Risk Factors

   tariff of 10% on all U.S. trading partners effective April 5, 2025, and higher individualized reciprocal tariffs on 57 countries
   17 matches in this document Show context Copy citation

5. XLO Xilio Therapeutics, Inc. 10-Q 2026-11-10

   Item 1A. Risk Factors

   tariffs, invalidating both the “reciprocal” tariffs and certain country-specific tariffs. The President subsequently invoked Section 122 of the Trade
   14 matches in this document Show context Copy citation

6. XLO Xilio Therapeutics, Inc. 10-Q 2026-08-12

   Item 1A. Risk Factors

   tariffs, invalidating both the “reciprocal” tariffs and certain country-specific tariffs. The President subsequently invoked Section 122 of the Trade
   14 matches in this document Show context Copy citation

7. XLO Xilio Therapeutics, Inc. 10-K 2026-03-23

   Item 1A. Risk Factors

   tariffs, invalidating both the “reciprocal” tariffs and certain country-specific tariffs. The President subsequently invoked Section 122 of the Trade
   11 matches in this document Show context Copy citation